Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application…
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application…
Roche gets FDA Priority Review for Enspryng TED
Roche (OTCQX:RHHBY) received FDA Priority Review for a supplemental Biologics License Application for…